| Malignancy after transplantation JF Buell, TG Gross, ES Woodle Transplantation 80 (2S), S254-S264, 2005 | 776 | 2005 |
| The immune cell landscape in kidneys of patients with lupus nephritis A Arazi, DA Rao, CC Berthier, A Davidson, Y Liu, PJ Hoover, A Chicoine, ... Nature immunology 20 (7), 902-914, 2019 | 697 | 2019 |
| Epstein-Barr virus-induced posttransplant lymphoproliferative disorders CV Paya, JJ Fung, MA Nalesnik, E Kieff, M Green, G Gores, ... Transplantation 68 (10), 1517-1525, 1999 | 622 | 1999 |
| A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy ES Woodle, MR First, J Pirsch, F Shihab, AO Gaber, P Van Veldhuisen, ... Annals of surgery 248 (4), 564-577, 2008 | 530 | 2008 |
| Bortezomib provides effective therapy for antibody-and cell-mediated acute rejection MJ Everly, JJ Everly, B Susskind, P Brailey, LJ Arend, RR Alloway, ... Transplantation 86 (12), 1754-1761, 2008 | 486 | 2008 |
| Alemtuzumab induction in renal transplantation MJ Hanaway, ES Woodle, S Mulgaonkar, VR Peddi, DB Kaufman, ... New England Journal of Medicine 364 (20), 1909-1919, 2011 | 445 | 2011 |
| Posttransplant lymphoproliferative disease in pediatric liver transplantation: interplay between primary Epstein-Barr virus infection and immunosuppression KA Newell, EM Alonso, PF Whitington, DS Bruce, JM Millis, JB Piper, ... Transplantation 62 (3), 370-375, 1996 | 298 | 1996 |
| Ethics of a paired-kidney-exchange program LF Ross, DT Rubin, M Siegler, MA Josephson, JR Thistlethwaite Jr, ... New England Journal of Medicine 336 (24), 1752-1755, 1997 | 259 | 1997 |
| De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population Y Miao, JJ Everly, TG Gross, AD Tevar, MR First, RR Alloway, ES Woodle Transplantation 87 (9), 1347-1359, 2009 | 257 | 2009 |
| Reducing de novo donor‐specific antibody levels during acute rejection diminishes renal allograft loss MJ Everly, JJ Everly, LJ Arend, P Brailey, B Susskind, A Govil, A Rike, ... American Journal of Transplantation 9 (5), 1063-1071, 2009 | 255 | 2009 |
| Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3γ1 (Ala-Ala) in the treatment of acute renal allograft rejection ES Woodle, D Xu, RA Zivin, J Auger, J Charette, R O'Laughlin, D Peace, ... Transplantation 68 (5), 608-616, 1999 | 248 | 1999 |
| Complications in 100 living-liver donors HP Grewal, JR Thistlethwaite Jr, GE Loss, JS Fisher, DC Cronin, ... Annals of surgery 228 (2), 214-219, 1998 | 233 | 1998 |
| Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients R Ferguson, J Grinyó, F Vincenti, DB Kaufman, ES Woodle, BA Marder, ... American Journal of Transplantation 11 (1), 66-76, 2011 | 227 | 2011 |
| The role of donor-specific HLA alloantibodies in liver transplantation JG O’leary, AJ Demetris, LS Friedman, HM Gebel, PF Halloran, AD Kirk, ... American Journal of Transplantation 14 (4), 779-787, 2014 | 221 | 2014 |
| Donor-transmitted malignancies in organ transplantation: assessment of clinical risk MA Nalesnik, ES Woodle, JM Dimaio, B Vasudev, LW Teperman, ... American Journal of Transplantation 11 (6), 1140-1147, 2011 | 221 | 2011 |
| Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection RC Walsh, JJ Everly, P Brailey, AH Rike, LJ Arend, G Mogilishetty, A Govil, ... Transplantation 89 (3), 277-284, 2010 | 219 | 2010 |
| Plasma-derived C1 esterase inhibitor for acute antibody-mediated rejection following kidney transplantation: results of a randomized double-blind placebo-controlled pilot study RA Montgomery, BJ Orandi, L Racusen, AM Jackson, JM Garonzik-Wang, ... American Journal of Transplantation 16 (12), 3468-3478, 2016 | 178 | 2016 |
| Portal vein thrombosis and stenosis in pediatric liver transplantation1 JM Millis, DS Seaman, JB Piper, EM Alonso, S Kelly, CA Hackworth, ... Transplantation 62 (6), 748-754, 1996 | 178 | 1996 |
| A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection: a report of the Tacrolimus Kidney Transplantation Rescue Study Group ES Woodle, JR Thistlethwaite, JH Gordon, D Laskow, MH Deierhoi, ... Transplantation 62 (5), 594-599, 1996 | 175 | 1996 |
| Immunosuppression and Merkel cell cancer JF Buell, J Trofe, MJ Hanaway, TM Beebe, TG Gross, RR Alloway, ... Transplantation proceedings 34 (5), 1780-1781, 2002 | 173 | 2002 |
Prabir Roy-ChaudhuryUniversity of ArizonaBestätigte E-Mail-Adresse bei deptofmed.arizona.edu
